TH9791A - - Google Patents
Info
- Publication number
- TH9791A TH9791A TH8901000064A TH8901000064A TH9791A TH 9791 A TH9791 A TH 9791A TH 8901000064 A TH8901000064 A TH 8901000064A TH 8901000064 A TH8901000064 A TH 8901000064A TH 9791 A TH9791 A TH 9791A
- Authority
- TH
- Thailand
- Prior art keywords
- group
- alkyl
- replaced
- carbon
- alkylines
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract 6
- 239000000126 substance Substances 0.000 claims abstract 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000000758 substrate Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102100028255 Renin Human genes 0.000 abstract 1
- 108090000783 Renin Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003943 azolyl group Chemical group 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Abstract
สารประกอบที่มีสูตร(สูตรเคมี) [ซึ่ง A คือพันธะคาร์บอน%คาร์บอน หรือ C1-C3 แอลคิลีน, B คือหมู่อิมิโน หรือ C1-C3 แอลคิลีน, R1 คือ C1-C4 แอลคิล, C1-C4 แอลคอกซิ, เฮเทอโรไซคลิคหรืออะมิโนที่เลือกให้ถูกแทน ที่, R2 คือเฟนิลที่เลือกให้ถูกแทนที่หรือแนฟธิลที่เลือก ให้ถูกแทนที่ R3 คือไธอะโซลิล, ไอซอกซาโซลิลหรืออิมิดาโซ ลิล, R4 คือไอโซโพรพิลหรือไซโคลเฮกซิล, R5 และ R6 คือ C1-C4 แอลคิล หรือรวมเข้าด้วยกันกับคาร์บอนซึ่งหมู่เหล่า นั้นต่ออยู่, C3-C7 ไซโคลแอลคิล, R7 คือไฮโดรเจน, หมู่ C1-C6 แอลคิลที่เลือกให้ถูกแทนที่, และ R8 คือไฮโดรเจนหรือ C1-C4 แอลคิล] มีการยับยั้งเรนินได้และโดยเหตุที่แสดงการออกฤทธิ์ลดความ ดันโลหิตและมีคุณค่าเป็นพิเศษในการวินิจฉัยโรคและการรักษา โรคความดันโลหิตสูงที่ถูกชักนำโดยความล้มเหลวในระบบเร นิล-แอนจิโอเทนซิล อาจเตรียมสารประกอบต่างๆนี้ได้โดยการทำ ปฏิกิริยาอะมิโนแอซิด ที่เหมาะสมหรืออนุพันธ์ของสารนั้น เข้าด้วยกัน : สิทธิบัตรยา Compounds with the formula (chemical formula) (where A is a% carbon bond or C1-C3 alkylines, B is an imino group or C1-C3 alkylines, R1 is C1-C4 alkyl. , C1-C4 alkoxy, heterocyclic or amino selected to be substituted, R2 is phenyl selected to be replaced or naphthyl selected to be replaced, R3 is thy. Azolyl, isoxazolyl or imidazolyl, R4 is isopropyl or cyclohexyl, R5 and R6 are C1-C4 alkyl or combined. With the carbon to which those groups are attached, C3-C7 cycloalkyl, R7 is hydrogen, C1-C6 alkyl selected to be replaced, and R8 is hydrogen or C1-C4 alkyl.) Renin has been inhibited and by acting Blood pressure and is of particular value in diagnosis and treatment. Hypertension that is induced by a failure in the system Onyx - Angiotensil These compounds may be prepared by: Amino acid reactions Suitable or derivative of that substance together: patent drugs.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH9791A true TH9791A (en) | 1991-11-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE33838T1 (en) | THIAZOLIDE DERIVATIVES, THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM. | |
| NO173446C (en) | Analogous Procedures for the Preparation of New, Therapeutically Active, Substituted Alkandiphosphonic Acids | |
| MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
| NO20021401L (en) | Quinazoline compounds and pharmaceutical preparations containing such compounds | |
| ATE51618T1 (en) | IMIDAZOL DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS. | |
| ZA935340B (en) | Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity | |
| FI884968A0 (en) | Process for the preparation of octahydronaphthalene oxime derivatives useful as a medicament | |
| KR950703557A (en) | Heteroaryl Compounds Used as Pharmaceuticals | |
| TH9791A (en) | ||
| BG101501A (en) | Nitro-benzamides useful as anti-arrhytmic agents | |
| NO173010C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHONANILIDE | |
| HUP9802543A2 (en) | Process for producing pharmaceuticals containing thiadiazolidinedione derivatives for reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus | |
| ATE78032T1 (en) | 2-PYRIDYLACETIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| PT96123A (en) | METHOD OF PREPARING A MEDICINAL PRODUCT FOR TREATMENT OF PNEUMOCYSTIS CARINII INFECTION | |
| ATE58129T1 (en) | COMPOUNDS SIMILAR TO ANTIBIOTIC TAN-749 AND THEIR PRODUCTION. | |
| EP0326364A3 (en) | Renin inhibitory oligopeptides, their preparation and use | |
| TH8968A (en) | Peptides with renin-inhibiting agility Preparation and benefits of these substances | |
| DK0868428T3 (en) | Phosphonic acid derivatives with metallopeptidase inhibitory activity | |
| NO903084L (en) | PHARMACEUTICAL USE OF THIAZOLD DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THEM. | |
| TH2011A (en) | Compound preparations which are useful in the treatment of hypertension. | |
| ATE44741T1 (en) | 2-(N-SUBSTITUTED GUANIDINO)-4HETEROARYLTHIAZOLE AS ANTI-ULCER AGENTS. | |
| TH22952A (en) | "Vitamin D derivative, use and process for preparing this substance" | |
| TH9839A (en) | Dolobenzocquinoline derivatives, their preparations and their use as an antiarrhythmic drug. | |
| TH2190A (en) | Preparation process N-Aerill-Alpha-Amino Carboxamied | |
| HUT69166A (en) | Process to preparare pharmaceutical compns. to prevent and to cure ulcus |